TipRanks
Advertisement
Advertisement
Levee Medical Reaches Enrollment Milestone in ARID II Pivotal Trial for Voro Urologic Scaffold
PremiumPrivate CompaniesLevee Medical Reaches Enrollment Milestone in ARID II Pivotal Trial for Voro Urologic Scaffold
3M ago
Levee Medical Completes Enrollment in Pivotal ARID II Trial for Voro Urologic Scaffold
Premium
Private Companies
Levee Medical Completes Enrollment in Pivotal ARID II Trial for Voro Urologic Scaffold
3M ago
Levee Medical Advances Pivotal ARID II Trial and Showcases Voro Scaffold at AUA 2026
Premium
Private Companies
Levee Medical Advances Pivotal ARID II Trial and Showcases Voro Scaffold at AUA 2026
5M ago
Levee Medical Emphasizes Pivotal Study Progress for Investigational Urologic Scaffold
PremiumPrivate CompaniesLevee Medical Emphasizes Pivotal Study Progress for Investigational Urologic Scaffold
5M ago
Levee Medical Advances ARID II Pivotal Trial for Voro Urologic Scaffold
Premium
Private Companies
Levee Medical Advances ARID II Pivotal Trial for Voro Urologic Scaffold
6M ago
Levee Medical Marks First-Patient Enrollment in ARID II Pivotal Trial
Premium
Private Companies
Levee Medical Marks First-Patient Enrollment in ARID II Pivotal Trial
6M ago
Levee Medical Highlights First-Patient Enrollment in Pivotal ARID II Trial for Voro Urologic Scaffold
PremiumPrivate CompaniesLevee Medical Highlights First-Patient Enrollment in Pivotal ARID II Trial for Voro Urologic Scaffold
7M ago
Levee Medical Highlights Patient Burden of Post-Prostatectomy Incontinence in Awareness Campaign
Premium
Private Companies
Levee Medical Highlights Patient Burden of Post-Prostatectomy Incontinence in Awareness Campaign
7M ago
Levee Medical Highlights Patient Burden of Post‑Prostatectomy Incontinence
Premium
Private Companies
Levee Medical Highlights Patient Burden of Post‑Prostatectomy Incontinence
7M ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―